T2 BIOSYSTEMS INC (TTOO)
US89853L3024 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.08M | 15.69M | 10.33M | 22.25M | 16.79M | |||
| Marketable Securities | N/A | N/A | 0.00 | 10.00M | 25.40M | |||
| Receivables | 2.03M | 1.42M | 2.16M | 5.13M | 5.10M | |||
| Inventories | 3.83M | 4.82M | 4.29M | 3.91M | 3.64M | |||
| Other Current Assets | 1.84M | 3.26M | 2.58M | 3.11M | 2.66M | |||
| Total Current Assets | 9.79M | 25.19M | 19.36M | 44.39M | 53.58M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.75M | 9.05M | 13.27M | 14.44M | 14.81M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 10.00M | |||
| Other Non-Current Assets | 551.00K | 555.00K | 1.69M | 1.70M | 690.00K | |||
| Total Non-Current Assets | 8.30M | 9.61M | 14.97M | 16.15M | 25.50M | |||
| TOTAL ASSETS | 18.08M | 34.80M | 34.33M | 60.54M | 79.08M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 11.92M | 41.28M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 7.66M | 11.33M | 8.62M | 8.34M | 7.51M | |||
| Accounts Payable | 4.21M | 1.53M | 1.30M | 2.83M | 2.06M | |||
| Other Current Liabilities | 646.00K | 2.01M | 210.00K | 520.00K | 230.00K | |||
| Total Current Liabilities | 24.43M | 56.15M | 10.13M | 11.69M | 9.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 49.65M | 47.79M | 45.24M | |||
| Other Non-Current Liabilities | 5.36M | 6.68M | 14.20M | 13.96M | 15.32M | |||
| Total Non-Current Liabilities | 5.36M | 6.68M | 63.85M | 61.75M | 60.55M | |||
| TOTAL LIABILITIES | 29.79M | 62.83M | 73.98M | 73.44M | 70.35M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -616.91M | -584.30M | -534.22M | -472.22M | -422.98M | |||
| Additional Paid In Capital | 605.18M | 556.26M | 494.56M | 459.15M | 431.54M | |||
| Common Shares | 18.00K | 4.00K | 10.00K | 170.00K | 150.00K | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | 10.00K | |||
| Shares Outstanding | 18.76M | 4.06M | 80.00K | 30.00K | 30.00K | |||
| Tangible Book Value per Share | -0.62 | -6.91 | -495.75 | -430.00 | 291.00 | |||
| Total Shareholders' Equity | -11.71M | -28.04M | -39.66M | -12.90M | 8.73M | |||
| TOTAL LIABILITIES AND EQUITY | 18.08M | 34.80M | 34.33M | 60.54M | 79.08M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | -1.25 | -3.70 | 5.18 | |||
| Current Ratio | 0.40 | 0.45 | 1.91 | 3.80 | 5.47 | |||
| Return On Assets (ROA) | -237.55% | -143.91% | -181.56% | -81.33% | -59.18% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | -536.08% | |||
All data in USD , ROIC based on taxRate of 0.21